82 related articles for article (PubMed ID: 1967239)
1. Reflux esophagitis in patients with Zollinger-Ellison syndrome.
Miller LS; Vinayek R; Frucht H; Gardner JD; Jensen RT; Maton PN
Gastroenterology; 1990 Feb; 98(2):341-6. PubMed ID: 1967239
[TBL] [Abstract][Full Text] [Related]
2. Esophageal Perforation Unveiling the Diagnosis of Zollinger-Ellison Syndrome.
Shaik MR; Shaik NA; Kunarathnam V; Bilgrami Z; Wheeler E; Hu S
J Community Hosp Intern Med Perspect; 2023; 13(5):77-81. PubMed ID: 37868662
[TBL] [Abstract][Full Text] [Related]
3. Successful Lifetime/Long-Term Medical Treatment of Acid Hypersecretion in Zollinger-Ellison Syndrome (ZES): Myth or Fact? Insights from an Analysis of Results of NIH Long-Term Prospective Studies of ZES.
Ito T; Ramos-Alvarez I; Jensen RT
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900170
[TBL] [Abstract][Full Text] [Related]
4. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.
Lee L; Ramos-Alvarez I; Ito T; Jensen RT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623145
[TBL] [Abstract][Full Text] [Related]
5. Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy.
Richter JE
Gastroenterol Hepatol (N Y); 2014 Sep; 10(9):547-55. PubMed ID: 27551249
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Treatment of Gastrinomas in Multiple Endocrine Neoplasia Type 1 (MEN-1).
Plöckinger U
Cancers (Basel); 2012 Jan; 4(1):39-54. PubMed ID: 24213225
[TBL] [Abstract][Full Text] [Related]
7. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
Ito T; Igarashi H; Uehara H; Berna MJ; Jensen RT
Medicine (Baltimore); 2013 May; 92(3):135-181. PubMed ID: 23645327
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of Zollinger-Ellison syndrome.
Ito T; Igarashi H; Uehara H; Jensen RT
Expert Opin Pharmacother; 2013 Feb; 14(3):307-21. PubMed ID: 23363383
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.
Ito T; Cadiot G; Jensen RT
World J Gastroenterol; 2012 Oct; 18(39):5495-503. PubMed ID: 23112541
[TBL] [Abstract][Full Text] [Related]
10. Oral proton-pump inhibitors and step-down therapy for nonulcer dyspepsia: is this the right approach?
Waldum HL; Martinsen TC; Hauso O; Qvigstad G
Therap Adv Gastroenterol; 2010 Mar; 3(2):73-6. PubMed ID: 21180591
[No Abstract] [Full Text] [Related]
11. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.
Kulke MH; Anthony LB; Bushnell DL; de Herder WW; Goldsmith SJ; Klimstra DS; Marx SJ; Pasieka JL; Pommier RF; Yao JC; Jensen RT;
Pancreas; 2010 Aug; 39(6):735-52. PubMed ID: 20664472
[TBL] [Abstract][Full Text] [Related]
12. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.
Jensen RT; Berna MJ; Bingham DB; Norton JA
Cancer; 2008 Oct; 113(7 Suppl):1807-43. PubMed ID: 18798544
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.
Metz DC; Jensen RT
Gastroenterology; 2008 Nov; 135(5):1469-92. PubMed ID: 18703061
[TBL] [Abstract][Full Text] [Related]
14. [Rare occurrence of fulminant acid burn of the esophagus].
Knebel C; Bumm R; Becker K; Burian M; Siewert JR
Chirurg; 2008 Aug; 79(8):765-70. PubMed ID: 17879075
[TBL] [Abstract][Full Text] [Related]
15. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
[TBL] [Abstract][Full Text] [Related]
16. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
[TBL] [Abstract][Full Text] [Related]
17. Surgery increases survival in patients with gastrinoma.
Norton JA; Fraker DL; Alexander HR; Gibril F; Liewehr DJ; Venzon DJ; Jensen RT
Ann Surg; 2006 Sep; 244(3):410-9. PubMed ID: 16926567
[TBL] [Abstract][Full Text] [Related]
18. What is potent acid inhibition, and how can it be achieved?
Calvet X; Gomollón F
Drugs; 2005; 65 Suppl 1():13-23. PubMed ID: 16335854
[TBL] [Abstract][Full Text] [Related]
19. Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion.
Gibril F; Jensen RT
Curr Gastroenterol Rep; 2004 Dec; 6(6):454-63. PubMed ID: 15527675
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
